Substituted triazole derivatives and application thereof in preparing an anti-tumor metastasis drug
A technology of triazoles and derivatives, which is applied in the field of triazole derivatives and their application in the preparation of anti-tumor metastasis drugs, can solve the problems of lack of effective treatment methods for tumor metastasis and low effectiveness of small molecules, etc. Achieve the effect of broad anti-tumor metastasis application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Example 1.2-Hydroxy-3-((5-phenyl-4H-1,2,4-triazol-3-yl)amino)-N,N-dimethylbenzamide (compound 1)
[0036]
[0037] Step 1. Synthesis of 3-(3-benzoylthioureido)-2-methoxy-N,N-dimethylbenzamide (intermediate 2)
[0038] Dissolve benzoyl chloride (182mg, 1.5mmol) in acetone, slowly add potassium thiocyanate (155mg, 1.6mmol) under stirring, stir at room temperature for 1h, then add 3-amino-2-methoxy-N,N- Dimethylbenzamide (Intermediate 1) (97mg, 0.5mmol), continue to react for 6h. After the reaction of the raw materials was complete, the solvent was recovered under reduced pressure, the residue was dissolved in water, extracted with ethyl acetate (50mL×3), the combined organic layers were washed with saturated brine, anhydrous Na 2 SO 4 After drying, the solvent was recovered under reduced pressure, and the residue was purified by column chromatography to obtain 120 mg of the target product (Intermediate 2) as a white solid, with a yield of 67%; 1 H NMR (500MHz, CDCl ...
Embodiment 2
[0042] Example 2.2-Hydroxy-3-((5-n-propyl-4H-1,2,4-triazol-3-yl)amino)-N,N-dimethylbenzamide (compound 2)
[0043]
[0044] Using Intermediate 1 and n-butyryl chloride as raw materials, according to the method of Example 1, Compound 2 was prepared with a yield of 42%; 1 H NMR (500MHz, Acetone) δ8.20(d, J=8.0Hz, 1H), 7.46(s, 1H), 6.98(d, J=7.8Hz, 1H), 6.85(t, J=7.9Hz, 1H ), 3.15(s, 6H), 2.68(t, J=7.5Hz, 2H), 1.82–1.72(m, 2H), 0.97(t, J=7.4Hz, 3H); ESI-MS: m / z= 290[M+H] + .
Embodiment 3
[0045] Example 3.3-((5-tert-butyl-4H-1,2,4-triazol-3-yl)amino)-2-hydroxy-N,N-dimethylbenzamide (compound 3)
[0046]
[0047] Using intermediate 1 and pivaloyl chloride as raw materials, according to the method of Example 1, compound 3 was prepared with a yield of 36%; 1 H NMR (500MHz, CDCl 3 )δ7.85(d, J=7.4Hz, 1H), 6.84(dd, J=7.8, 1.5Hz, 1H), 6.77(t, J=7.9Hz, 1H), 3.12(s, 6H), 1.36( s,9H); ESI-MS: m / z=304[M+H] + .
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


